Supporting research in human populations to understand determinants of cancer occurrence and outcomes and translating findings to clinical and public health interventions.
Funding Opportunities
Stephen I. Katz Early Stage Investigator Research Project Grant
PAR-24-075 (R01 - Clinical Trial Not Allowed)
PAR-24-076 (R01 - Basic Experimental Studies with Humans Required)
Expires December 29, 2026
Assay Validation of High Quality Markers for Clinical Studies in Cancer
PAR-23-313 (UH2/UH3 – Clinical Trial Not Allowed)
PAR-23-314 (UH3 – Clinical Trials Not Allowed)
Expires October 15, 2026
Impacts of Climate Change Across he Cancer Control Continuum
PAR-23-153 (R01 - Clinical Trial Optional) and PAR-23-152 (R21 - Clinical Trial Optional)
Expires May 8, 2026
Pragmatic Trials Across the Cancer Control Continuum
PAR-22-256 (UG3/UH3 - Clinical Trial Required)
Expires November 18, 2025
Investigator-Initiated Research in Genomics and Health Equity
RFA-HG-23-017 (R01 - Clinical Trial Optional)
Expires July 9, 2025
ClinGen Genomic Curation Expert Panels
PAR-23-199 (U24 - Clinical Trial Not Allowed)
Expires May 26, 2025
Epidemiologic Research on Emerging Risk Factors and Liver Cancer Susceptibility
PAR-22-083 (R01 - Clinical Trial Not Allowed) and PAR-22-084 (R21 - Clinical Trial Not Allowed)
Expires May 8, 2025
Cancer Epidemiology Cohorts: Building the Next Generation of Research Cohorts
PAR-22-161 (U01 - Clinical Trial Not Allowed)
Expires March 1, 2025
Research Opportunities in Established Cancer Epidemiology Cohort Studies
PAR-22-162 (U01 - Clinical Trial Not Allowed)
Expires March 1, 2025
Notice of Special Interest: Technology Development for Cancer Control and Population Science Research
NOT-CA-23-037
Expires December 31, 2024
Exploratory Grants in Cancer Control
PAR-21-341 (R21 - Clinical Trial Optional)
Expires October 9, 2024
Time-Sensitive Obesity Policy and Program Evaluation
PAR-21-305 (R01 - Clinical Trial Not Allowed)
Expires September 11, 2024
Notice of Special Interest: Administrative Supplements for Contemporary Modifiable Exposures and Cancer Across the Life Course and Cancer Control Continuum
NOT-CA-24-030
Expires April 23, 2024
Notice of Special Interest: Administrative Supplement for Research and Capacity Building Efforts Related to Bioethical Issues
NOT-OD-24-031 (Admin Supp - Clinical Trial Optional)
Expires April 1, 2024
Featured Resource
Healthy Eating Index (HEI)
The HEI is a scoring metric that can be used to determine overall diet quality, as well as the quality of several dietary components. HEI–2020 is the most recent version of the index for the American population age 2 years and older, and new in 2023 is the HEI-Toddlers-2020, which was created to align with new dietary recommendations for young children in the 2020-2025 Dietary Guidelines for Americans.
Featured Resource
Genomic Summary Results
Genomic summary results (GSR) serve as a valuable resource for cancer epidemiology researchers. Learn more about GSR, their significance in cancer epidemiology research, guidelines for sharing GSR data, and where such data can be accessed.
What's New
Connect With Us
Subscribe for Updates
Subscribe
You can subscribe and unsubscribe at any time by entering your email address and selecting your preferences on the page that follows.
Need Help?
EGRP staff can answer questions on grant funding, policies, and research resources. If you do not know who to contact we will do our best to connect you with someone who can help you.
Email Us(240) 276-6730
Follow Us on LinkedIn!
Are you interested in gaining access to funding opportunities, event information, and research insights from NCI’s Division of Cancer Control and Population Sciences (DCCPS)? We invite you to follow the DCCPS LinkedIn page.
Follow DCCPS